Weekly Recap

Lemborexant Shows Positive Medication Effect, New Comparative Study for CGRPs Announced, Ultra-Early Epilepsy Surgery Effective

July 03, 2021

Neurology News Network for the week ending July 2, 2021.

Eptinezumab Demonstrates Rapid Relief, Zolgensma Improves Motor Function in SMA, RELIEF Study Results

June 26, 2021

Neurology News Network for the week ending June 26, 2021.

Blarcamesine Exceeds Enrollment, Higher Plasma Nusinersen Leads to Meaningful Improvements, Neurodevelopmental Outcomes Unchanged by Maternal ASMs

June 19, 2021

Neurology News Network for the week ending June 19, 2021.

Telemedicine Produces Meaningful Migraine Improvement, Galcanezumab Shows No Wearing Effect, CGRPs All Significant Improve MMDs

June 12, 2021

Neurology News Network for the week ending June 12, 2021.

Experts Call for Better Trial Design, Alzheimer Disease Vaccine Shows Safety, FDA Accepts IND for LION-101

June 05, 2021

Neurology News Network for the week ending June 5, 2021.

ANVS401 Shows Promise in Alzheimer Disease, FDA Approves IND for Ketamine in Parkinson, MedRhythms Collaborates With Massachusetts General Hospital

May 29, 2021

Neurology News Network for the week ending May 29, 2021.

ET Associated With Substantial HCRU, MS Phenotypes Share Common Mechanisms, Hypertension Risk in Menopausal Women With Migraine

May 22, 2021

Neurology News Network for the week ending May 22, 2021.

Gene Therapy in SLC13A5 Deficiency, DMTs Reduce Risk of Disability in Pediatric MS, FASTEST Phase 3 Study Announced

May 15, 2021

Neurology News Network for the week ending May 15, 2021.

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

May 08, 2021

Neurology News Network for the week ending May 8, 2021.

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

May 01, 2021

Neurology News Network for the week ending May 1, 2021.